A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Immunotherapy as an Antifungal Strategy in Immune Compromised Hosts
2020
Current Clinical Microbiology Reports
Purpose of Review IFIs cause high morbidity and mortality in the immunocompromised host worldwide. Although highly effective, conventional antifungal chemotherapy faces new challenges due to late diagnosis and increasing numbers of drugresistant fungal strains. Thus, antifungal immunotherapy represents a viable treatment option, and recent advances in the field are summarized in this review. Recent Findings Antifungal immunotherapies include application of immune cells as well as the
doi:10.1007/s40588-020-00141-9
fatcat:eqeco2ocbvbwjp7hp746ifczdq